138 results on '"Nelson, David L."'
Search Results
2. Functional consequences of postnatal interventions in a mouse model of Fragile X syndrome
3. Stephen T. Warren, Ph.D. (1953–2021): A remembrance
4. Simultaneous Screening of the FRAXA and FRAXE Loci for Rapid Detection of FMR1 CGG and/or AFF2 CCG Repeat Expansions by Triplet-Primed PCR
5. 2019 McKusick Leadership Award Introduction: Huda Zoghbi
6. 2018 Presidential Address: Who Are We?
7. TPT sulfonate, a single, oral dose schistosomicidal prodrug: In vivo efficacy, disposition and metabolic profiling
8. ASHG Perspectives: A New Voice for ASHG
9. The preparation of benzyl esters using stoichiometric niobium (V) chloride versus niobium grafted SiO2 catalyst: A comparison study
10. Turning the corner from observation to intervention in human genetics
11. So Long, and Thanks for All the Genes!
12. Human serine racemase structure/activity relationship studies provide mechanistic insight and point to position 84 as a hot spot for β-elimination function
13. 2016 William Allan Award Introduction: James Gusella 1
14. Increased serum soluble interleukin-2 receptors in caucasian and Korean schizophrenic patients
15. FXR1P Limits Long-Term Memory, Long-Lasting Synaptic Potentiation, and De Novo GluA2 Translation
16. Trigger Finger: Assessment of Surgeon and Patient Preferences and Priorities for Decision Making
17. Contamination of cachaça by PAHs from storage containers
18. Randomized Trial of Bilevel versus Continuous Positive Airway Pressure for Acute Pulmonary Edema
19. Autoverification in a core clinical chemistry laboratory at an academic medical center
20. Demonstration of an Effective Postoperative Pain Management Protocol in Distal Radius Fractures
21. A multi-sensor plume height analysis of the 2009 Redoubt eruption
22. Extracts from the leaves of Piper piscatorum (Trel. Yunc.) obtained by supercritical extraction of with CO2, employing ethanol and methanol as co-solvents
23. The Unstable Repeats—Three Evolving Faces of Neurological Disease
24. AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome
25. Unleashing a “True” pSer-Mimic in the Cell
26. Book review
27. A Century beyond the Fly Room
28. AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome
29. Response to “Toward unified satellite climatology of aerosol properties. 3. MODIS versus MISR versus AERONET”
30. Impact of endotracheal tube size on preextubation respiratory variables
31. Ultrastructural analysis of the functional domains in FMRP using primary hippocampal mouse neurons
32. Use of fluorinated functionality in enzyme inhibitor development: Mechanistic and analytical advantages
33. Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice
34. Fragile X-Related Proteins Regulate Mammalian Circadian Behavioral Rhythms
35. Indoloxypropanolamine analogues as 5-HT1A receptor antagonists
36. RNA-Binding Proteins hnRNP A2/B1 and CUGBP1 Suppress Fragile X CGG Premutation Repeat-Induced Neurodegeneration in a Drosophila Model of FXTAS
37. Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes
38. NEMO, NFκB signaling and incontinentia pigmenti
39. Interruptions in the Expanded ATTCT Repeat of Spinocerebellar Ataxia Type 10: Repeat Purity as a Disease Modifier?
40. Using angular and spectral shape similarity constraints to improve MISR aerosol and surface retrievals over land
41. Somatic and Germline Instability of the ATTCT Repeat in Spinocerebellar Ataxia Type 10
42. Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4
43. Substituted furo[3,2-b]pyridines: novel bioisosteres of 5-HT1F receptor agonists
44. Molecular cloning and pharmacological characterization of the guinea pig 5-HT1E receptor
45. B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro
46. Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3
47. Advances Toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 2
48. Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1
49. Instability of a Premutation-Sized CGG Repeat in FMR1 YAC Transgenic Mice
50. The Human Secretin Gene: Fine Structure in 11p15.5 and Sequence Variation in Patients with Autism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.